Categories: Technology

$2,500 Lets Accredited Investors Back Ukraines Defense and Dual-Use Innovation with Pravo Ventures

Photo courtesy of Pravo Ventures

WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — A new U.S. platform is opening a secure, regulated pathway for accredited investors to participate in Ukraine’s fast-evolving defense and deep-tech economy—with investments starting at just $2,500.

Pravo Ventures, a Washington-based syndicate, connects American investors with Ukrainian startups that develop defense, dual-use, and frontier-technology solutions, sourced from the country’s leading accelerators and innovation clusters. Each deal is structured through standard U.S. special-purpose vehicles (SPVs) under SEC Reg D 506(c), giving investors familiar documentation, dollar-denominated instruments, and streamlined online workflows.

“Much of Ukraine’s resilience stems from its founders’ ability to innovate under fire,” said Hans Braunfisch, Pravo’s founder and former PwC Manager for Geopolitical Investing. “As policy shifts, we’re providing a private-sector solution to a public-sector problem—making it simple and accessible for Americans to back Ukraine’s innovators directly.”

Pravo sources opportunities from leading Ukrainian incubators and innovation hubs, including eō Business Incubators, Techosystem, Brave Innovators, and the Brave1 investor community, which has reviewed hundreds of defense-tech ventures and distributed over $30 million in grants.

It’s closed; an invitation-only model protects founder IP and operational security while providing members with ongoing visibility into dozens of active opportunities each month.

Members also gain access to Pravo’s Intelligence Hub, which features concise investor briefings and the five-minute Ukraine Bulletin podcast led by Head of Intelligence and OSINT expert Vlad Sutea. The reports deliver scenario-based insights on Ukraine’s wartime economy and the technologies shaping its recovery—helping investors separate signal from noise.

Featured in Business Insider, Handelsblatt, and The Kyiv Independent, Pravo positions itself as a bridge between U.S. capital and Ukraine’s innovation economy—aligning financial returns with democratic resilience.

Accredited investors can apply for membership on the website. Participation includes access to proprietary intelligence briefings and curated deal flow. Investments begin at $2,500.

Pravo Ventures Inc. operates under Reg D 506(c) exemptions for accredited investors only. This release is for informational purposes and does not constitute an offer to sell or a solicitation to buy securities.

About Pravo Ventures

Founded in 2024, Pravo Ventures is the first U.S. platform linking accredited investors to Ukrainian startups. Based in Washington, D.C., and co-founded by Hans Braunfisch, Alex Ishin, and Vlad Sutea, it combines fintech efficiency with geopolitical purpose. By working with eō Business Incubators and the Brave1 ecosystem, Pravo brings access to vetted, battlefield-tested innovation. Its mission is twofold: broaden American access to frontier markets and provide Ukrainian founders with affordable capital.

Contact Information

Hans Braunfisch, Founder
Pravo Ventures
hans@pravoventures.com
http://www.pravoventures.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/682c31f6-2fcb-413e-8f4b-2b71cc887203 

GlobeNews Wire

Recent Posts

China takes the lead in all Industry 4.0 technologies, ahead of U.S. and Europe

MHP and LMU Munich publish eighth edition of the Industry 4.0 Barometer China takes the…

15 hours ago

Craft,Confidence,andCreativity:WomenMakersandthePowerBehindtheToAutoCommunity

Shenzhen, March 17, 2026 (GLOBE NEWSWIRE) -- On March 8, International Women’s Day, the ToAuto…

15 hours ago

Lantronix to Showcase Intelligent PoE Infrastructure and Edge AI Solutions for Autonomous Systems at ISC West 2026

IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider…

15 hours ago

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: SAB Biotherapeutics, Inc. MIAMI, March 17, 2026 (GLOBE…

19 hours ago

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: CytomX Therapeutics Inc. SOUTH SAN FRANCISCO, Calif., March…

19 hours ago

Blood Sugar Harmony Liquid Drops Ingredients Disclosed: Complete Details Revealed

Tallmadge, OH, March 17, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This content is for informational purposes…

19 hours ago